Overview A Clinical Pharmacology Study of K-877 Controlled Release Tablet Status: Completed Trial end date: 2020-03-31 Target enrollment: Participant gender: Summary A study to compare the efficacy, safety, and pharmacokinetics of K-877 controlled release tablets with a current normal K-877 tablet in dyslipidemia. Phase: Phase 2 Details Lead Sponsor: Kowa Company, Ltd.